| Dom34 mediates targeting of exogenous RNA in the antiviral OAS/RNase L pathway T Nogimori, K Nishiura, S Kawashima, T Nagai, Y Oishi, N Hosoda, ... Nucleic acids research 47 (1), 432-449, 2019 | 33 | 2019 |
| mTOR-and LARP1-dependent regulation of TOP mRNA poly (A) tail and ribosome loading K Ogami, Y Oishi, K Sakamoto, M Okumura, R Yamagishi, T Inoue, ... Cell reports 41 (4), 2022 | 18 | 2022 |
| The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses A Kawai, Y Yamamoto, T Nogimori, K Takeshita, T Yamamoto, Y Yoshioka Journal of Virology 95 (20), 10.1128/jvi. 01180-21, 2021 | 18 | 2021 |
| A novel method for stabilizing microRNA mimics T Nogimori, K Furutachi, K Ogami, N Hosoda, S Hoshino Biochemical and biophysical research communications 511 (2), 422-426, 2019 | 18 | 2019 |
| saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern M Komori, T Nogimori, AL Morey, T Sekida, K Ishimoto, MR Hassett, ... Nature Communications 14 (1), 2810, 2023 | 12 | 2023 |
| OMIP 078: A 31‐parameter panel for comprehensive immunophenotyping of multiple immune cells in human peripheral blood mononuclear cells T Nogimori, Y Sugawara, M Higashiguchi, H Murakami, H Akita, ... Cytometry Part A 99 (9), 893-898, 2021 | 11 | 2021 |
| Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study W Akahata, T Sekida, T Nogimori, H Ode, T Tamura, K Kono, Y Kazami, ... Cell Reports Medicine 4 (8), 2023 | 10 | 2023 |
| OMIP 075: A 22‐color panel for the measurement of antigen‐specific T‐cell responses in human and nonhuman primates T Nogimori, E Moriishi, M Ikeda, S Takahama, T Yamamoto Cytometry Part A 99 (9), 884-887, 2021 | 8 | 2021 |
| Simultaneous monitoring assay for T-cell receptor stimulation-dependent activation of CD4 and CD8 T cells using inducible markers on the cell surface S Takahama, T Nogimori, M Higashiguchi, H Murakami, H Akita, ... Biochemical and Biophysical Research Communications 571, 53-59, 2021 | 7 | 2021 |
| ABCE1 acts as a positive regulator of exogenous RNA decay T Nogimori, K Ogami, Y Oishi, R Goda, N Hosoda, Y Kitamura, Y Kitade, ... Viruses 12 (2), 174, 2020 | 6 | 2020 |
| LARP1 facilitates translational recovery after amino acid refeeding by preserving long poly (A)-tailed TOP mRNAs K Ogami, Y Oishi, T Nogimori, K Sakamoto, S Hoshino BioRxiv, 716217, 2019 | 5 | 2019 |
| Lysosomal acid lipase regulates bioenergetic process during the cytodifferentiation of human periodontal ligament cells T Nantakeeratipat, C Fujihara, T Nogimori, M Matsumoto, T Yamamoto, ... Biochemical and Biophysical Research Communications 662, 84-92, 2023 | 2 | 2023 |
| Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination T Nogimori, K Suzuki, Y Masuta, A Washizaki, M Yagoto, M Ikeda, ... Frontiers in Immunology 13, 1081047, 2023 | 2 | 2023 |
| Model for predicting age-dependent safety and immunomodulatory effects of STING ligands in non-human primates S Takahama, K Ishige, T Nogimori, Y Yasutomi, V Appay, T Yamamoto Molecular Therapy Methods & Clinical Development 28, 99-115, 2023 | 1 | 2023 |
| mRNA vaccine induces cytotoxic CD8+ T-cell cross-reactivity against SARS-CoV-2 Omicron variant and regulates COVID-19 severity T Nogimori, K Suzuki, Y Masuta, M Yagoto, M Ikeda, Y Katayama, ... | 1 | 2022 |
| Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients K Kawashiro, R Suzuki, T Nogimori, S Tsujino, N Iwahara, T Hirose, ... Scientific Reports 14 (1), 12176, 2024 | | 2024 |
| Comprehensive Immunophenotyping by Polychromatic Cytometry T Nogimori, T Yamamoto Flow Cytometry Protocols, 85-97, 2024 | | 2024 |
| SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020–2022 W Inoue, Y Kimura, S Okamoto, T Nogimori, A Sakaguchi-Mikami, ... Viruses 16 (3), 446, 2024 | | 2024 |
| Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipients T Nogimori, Y Nagatsuka, S Kobayashi, H Murakami, Y Masuta, K Suzuki, ... Communications Medicine 4 (1), 30, 2024 | | 2024 |
| Neutralizing antibody responses and cellular responses against severe acute respiratory syndrome coronavirus 2 omicron subvariant BA. 5 after an mRNA severe acute respiratory … K Kawashiro, R Suzuki, T Nogimori, N Iwahara, T Hirose, K Okada, ... bioRxiv, 2023.08. 02.551424, 2023 | | 2023 |
